Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 34, Issue 2, 2015, Pages 359-364

  Vassilopoulos, Dimitrios ^a   Gravos, Athanasios ^a   Vlachopoulos, Charalambos ^a   Kandili, Anna ^a   Ioakeimidis, Nikolaos ^a   Pectasides, Dimitrios ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Arterial stiffness; Methotrexate; Rheumatoid arthritis; TNF antagonists

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

AGED; ARTERIAL STIFFNESS; ARTHRITIS, RHEUMATOID; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84939896264     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2718-8     Document Type: Article

References (25)

1. Angel K, Provan SA, Gulseth HL et al (2010) Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 55:333–8
2. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24
3. Arosio E, De MS, Rigoni A et al (2007) Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 25:1273–8
4. Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) 63:522–9
5. Cypiene A, Laucevicius A, Venalis A et al (2007) Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc West Pharmacol Soc 50:119–22
6. Daien CI, Duny Y, Barnetche T et al (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71:862–8
7. Dulai R, Perry M, Twycross-Lewis R et al (2012) The effect of tumor necrosis factor-alpha antagonists on arterial stiffness in rheumatoid arthritis: a literature review. Semin Arthritis Rheum 42:1–8
8. Galarraga B, Khan F, Kumar P et al (2009) Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 48:1418–23
9. Greenberg JD, Kremer JM, Curtis JR et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:576–82
10. Inaba M, Tanaka K, Goto H et al (2007) Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol 34:290–5
11. Komai N, Morita Y, Sakuta T et al (2007) Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385–90
12. Kramer HR, Giles JT (2011) Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care Res (Hoboken) 63:484–99
13. Maki-Petaja KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114:1185–92
14. Mathieu S, Pereira B, Dubost JJ et al (2012) No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. Rheumatology (Oxford) 51:1107–11
15. McKellar GE, McCarey DW, Sattar N et al (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6:410–7
16. Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–31
17. Pieringer H, Stuby U, Pohanka E et al (2010) Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab. Clin Rheumatol 29:723–7
18. Tam LS, Shang Q, Li EK et al (2012) Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis—a randomized trial. J Rheumatol 39:2267–75
19. Van DS, McColl G, Jenkins A et al (2003) Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 48:72–80
20. Van DS, McColl G, Wicks IP (2005) Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 44:1428–32
21. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–27
22. Vlachopoulos C, Dima I, Aznaouridis K et al (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112:2193–200
23. Vlachopoulos C, Hirata K, O'Rourke MF (2001) Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections. Hypertension 38:1456–60
24. Westlake SL, Colebatch AN, Baird J et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49:295–307
25. Wong M, Oakley SP, Young L et al (2009) Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 68:1277–84